Clinical Trial Update: Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. [Phase 4]

View source ↗

Summary

This clinical trial update examines the effects of an IL-6 receptor inhibitor on clinical response and biomarkers in rheumatoid arthritis patients who did not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• IL-6 receptor inhibitor

Snippet

Sponsor: Osservatorio Epidemiologico GISEA | Conditions: Rheumatoid Arthritis (RA) | Phase 4 | Status: UNKNOWN